# A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

> **NCT06007846** · PHASE2,PHASE3 · RECRUITING · sponsor: **Inova Health Care Services** · enrollment: 12 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Cirrhosis

## Interventions

- **DRUG:** Namenda

## Key facts

- **NCT ID:** NCT06007846
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-31
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06007846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06007846, "A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06007846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*